OA12487A - Multiple target test useful for pre-donation screening of blood. - Google Patents
Multiple target test useful for pre-donation screening of blood. Download PDFInfo
- Publication number
- OA12487A OA12487A OA1200300155A OA1200300155A OA12487A OA 12487 A OA12487 A OA 12487A OA 1200300155 A OA1200300155 A OA 1200300155A OA 1200300155 A OA1200300155 A OA 1200300155A OA 12487 A OA12487 A OA 12487A
- Authority
- OA
- OAPI
- Prior art keywords
- different
- capture
- targets
- dipstick
- target
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 69
- 239000008280 blood Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 42
- 238000012216 screening Methods 0.000 title abstract description 13
- 239000012488 sample solution Substances 0.000 claims abstract description 36
- 239000000523 sample Substances 0.000 claims description 26
- 239000000427 antigen Substances 0.000 claims description 25
- 102000036639 antigens Human genes 0.000 claims description 25
- 108091007433 antigens Proteins 0.000 claims description 25
- 239000007790 solid phase Substances 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 244000005700 microbiome Species 0.000 claims description 14
- 239000012678 infectious agent Substances 0.000 claims description 11
- 239000011859 microparticle Substances 0.000 claims description 10
- 239000003446 ligand Substances 0.000 claims description 9
- 241000224016 Plasmodium Species 0.000 claims description 6
- 238000002372 labelling Methods 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 230000004520 agglutination Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- 239000008279 sol Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 21
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000009429 distress Effects 0.000 abstract description 3
- 241000700721 Hepatitis B virus Species 0.000 description 14
- 241000725303 Human immunodeficiency virus Species 0.000 description 14
- 239000003550 marker Substances 0.000 description 14
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 12
- 239000010931 gold Substances 0.000 description 12
- 229910052737 gold Inorganic materials 0.000 description 12
- 230000001745 anti-biotin effect Effects 0.000 description 7
- 230000036436 anti-hiv Effects 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000031886 HIV Infections Diseases 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 102100031673 Corneodesmosin Human genes 0.000 description 2
- 101710139375 Corneodesmosin Proteins 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003593 chromogenic compound Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 101800000385 Transmembrane protein Proteins 0.000 description 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5764—Hepatitis B surface antigen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0031391.6A GB0031391D0 (en) | 2000-12-21 | 2000-12-21 | Pre-donation testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12487A true OA12487A (en) | 2006-05-24 |
Family
ID=9905695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200300155A OA12487A (en) | 2000-12-21 | 2001-12-21 | Multiple target test useful for pre-donation screening of blood. |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN1486425A (zh) |
| AP (1) | AP1730A (zh) |
| AU (1) | AU2002216285A1 (zh) |
| GB (1) | GB0031391D0 (zh) |
| OA (1) | OA12487A (zh) |
| WO (1) | WO2002050544A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE544519T1 (de) * | 2004-12-13 | 2012-02-15 | Bayer Healthcare Llc | Unabhängiger testsensor |
| CN101246168B (zh) * | 2008-01-29 | 2013-07-24 | 马义才 | 一种便携式性病多合一快速联检装置 |
| WO2021134307A1 (zh) * | 2019-12-30 | 2021-07-08 | 深圳迈瑞生物医疗电子股份有限公司 | 用于检测传染性疾病的试剂盒、方法及免疫分析仪 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141850A (en) * | 1990-02-07 | 1992-08-25 | Hygeia Sciences, Inc. | Porous strip form assay device method |
| EP0566695B1 (en) * | 1991-01-11 | 1999-06-02 | Quidel Corporation | A one-step lateral flow assay and nonbibulous support used therein |
| WO1994023299A1 (en) * | 1993-03-31 | 1994-10-13 | Quidel Corporation | Multiple assay device |
| EP0705426A4 (en) * | 1993-06-09 | 1998-07-08 | Quidel Corp | SPECIFIC ONE-STEP TITRATIONS OF AN ANTIGEN |
| WO1995027081A1 (en) * | 1994-03-31 | 1995-10-12 | E.I. Du Pont De Nemours And Company | A method for detection of nucleic acid fragments |
| JPH10511460A (ja) * | 1994-12-22 | 1998-11-04 | アボツト・ラボラトリーズ | 被験サンプル中の複数分析物の時差式検出方法 |
| US5741662A (en) * | 1995-12-18 | 1998-04-21 | Quidel Corporation | Direct stain specific binding assays for microorganisms |
| JP2000506610A (ja) * | 1996-03-14 | 2000-05-30 | スペクトラル ダイアグノスティックス，インコーポレイテッド | 免疫測定装置 |
| WO1998036278A1 (en) * | 1997-02-15 | 1998-08-20 | Beth Israel Deaconess Medical Center, Inc. | Multiple-site antibody capture immunoassays and kits |
-
2000
- 2000-12-21 GB GBGB0031391.6A patent/GB0031391D0/en not_active Ceased
-
2001
- 2001-12-21 AP APAP/P/2003/002815A patent/AP1730A/en active
- 2001-12-21 OA OA1200300155A patent/OA12487A/en unknown
- 2001-12-21 AU AU2002216285A patent/AU2002216285A1/en not_active Abandoned
- 2001-12-21 CN CNA018221173A patent/CN1486425A/zh active Pending
- 2001-12-21 WO PCT/GB2001/005792 patent/WO2002050544A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002050544A1 (en) | 2002-06-27 |
| AP1730A (en) | 2007-03-30 |
| AP2003002815A0 (en) | 2003-06-30 |
| AU2002216285A1 (en) | 2002-07-01 |
| GB0031391D0 (en) | 2001-02-07 |
| CN1486425A (zh) | 2004-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lieberman et al. | Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti‐HBe status in HBsAg carriers | |
| CA2396116C (en) | Immunochromatographic assay devices with separators | |
| JP4851507B2 (ja) | 二経路免疫アッセイ装置 | |
| CA2187904A1 (en) | Home test kit and method with telephone verification of results | |
| US20180292401A1 (en) | Immunoassay Utilizing Trapping Conjugate | |
| OA12487A (en) | Multiple target test useful for pre-donation screening of blood. | |
| DE3636540A1 (de) | Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren | |
| Pepose et al. | New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections | |
| CN105807070B (zh) | 一种检测乙肝病毒的试剂盒 | |
| Alter et al. | The Ausria test: critical evaluation of sensitivity and specificity | |
| US20090104630A1 (en) | Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent | |
| Gunson et al. | HIV antibody screening of blood donations in the United Kingdom | |
| EP0196873B1 (en) | Diagnostic testing for micro-organisms | |
| EP1947458A1 (en) | Using colour conjugated chitosan and chitosan oligo-saccharides in the manufacture of a lateral-flow test device | |
| Henein et al. | HIV, hepatitis B, and hepatitis C in the code one trauma... | |
| AU743937B2 (en) | Reagent system and kit for detecting HIV infected cells | |
| Gust et al. | The detection of hepatitis B surface antigen by radioimmunoassay | |
| Gitnick et al. | Non-A, non-B hepatitis: A prospective study of a hemodialysis outbreak with evaluation of a serologic marker in patients and staff | |
| Wolters et al. | Detection of human antibodies to hepatitis B surface antigen (HBsAg) by an enzyme-immunoassay for HBsAg. | |
| KORGAONKAR et al. | Evaluation of HBsAg carrier rate in acute viral hepatitis and high risk individuals using RPHA and ELISA | |
| Mohammed | Serodetection of HBV, HCV, HIV and Treponema pallidum among Blood Donors in Almak Nimir University Hospital, Shendi, Sudan | |
| Wisnom et al. | Clinical applications of two detection systems for HIV using saliva | |
| Kumar et al. | Diffusion-in-gel enzyme-linked immunosorbent assay, ELISA and IFA test in the detection of malarial antibodies | |
| Rollag et al. | The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV‐infected hemophiliacs | |
| Lee et al. | Investigation on the Positive Rate of HBsAg in the Donor’s Blood |